|
|
||||||||
Viewpoint |
1 Department of Psychiatry,
2 Departments of Pediatrics and Human Genetics; Committees on Clinical Pharmacology and Pharmacogenomics, Molecular Medicine, Genetics, The University of Chicago, Chicago, Illinois 60637
Correspondence: EHC ed{at}yoda.bsd.uchicago.edu; fax 773-834-0505.
SUMMARY
A second form of tryptophan hydroxylase (TPH) is expressed in the brain by the gene Tph2. The presence of the gene was discovered when Tph 1/mice were found to express normal amounts of serotonin in brain, but not in the periphery. Additionally, Tph1/ mice showed no observed behavioral differences from wild-type littermates. Veenstra-Vanderweele and Cook discuss the ramifications of these findings and what they might mean for designing drugs that target the expression and activity of TPH in differing tissues.
Related articles in MI:
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ASPET Journals | Pharmacological Reviews | Drug Metabolism and Disposition |
| Molecular Interventions | Molecular Pharmacology | J Pharmacology and Exp Therapeutics |